Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode

Reference

• Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. 1982. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17:639–654.
   PubMed Web of Science ®Google Scholar
• Adler LE, Olincy A, Cawthra EM, McRae KA, Harris JG, Nagamoto HT, et al. 2004. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry 161:1822–1828.
   PubMed Web of Science ®Google Scholar
• Arnfred S. 2006. Exploration of auditory P50 gating in schizophrenia by way of difference waves. Behav Brain Funct 2:6.
   PubMedGoogle Scholar
• Blumenfeld LD, Clementz BA. 2001. Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG. Clin Neurophysiol 112:1650–1659.
   PubMed Web of Science ®Google Scholar
• Boutros NN, Belger A. 1999. Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating. Biol Psychiatry 45:917–922.
   PubMed Web of Science ®Google Scholar
• Boutros NN, Overall J, Zouridakis G. 1991. Test-retest reliability of the P50 mid-latency auditory evoked response. Psychiatry Res 39:181–192.
   PubMed Web of Science ®Google Scholar
• Boutros NN, Korzyuko O, Oliwa G, Feingold A, Campbell D, McClain-Furmanski D, et al. 2004a. Morphological and latency abnormalities of the mid-latency auditory evoked responses in schizophrenia: a preliminary report. Schizophr Res 70:303–313.
   PubMed Web of Science ®Google Scholar
• Boutros NN, Korzyukov O, Jansen B, Feingold A, Bell M. 2004b. Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res 126:203–215.
   PubMed Web of Science ®Google Scholar
• Boutros, NN, Gooding D, Sundaresan K, Burroughs S, Johanson CE. 2006. Cocaine-dependence and cocaine-induced paranoia and mid-latency auditory evoked responses and sensory gating. Psychiatry Res 145:147–154.
   PubMed Web of Science ®Google Scholar
• Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S. 2004. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 70:315–329.
   PubMed Web of Science ®Google Scholar
• Bramon E, Shaikh M, Broome M, Lappin J, Bergé D, Day F, et al. 2008. Abnormal P300 in people with high risk of developing psychosis. Neuroimage 41:553–560.
   PubMed Web of Science ®Google Scholar
• Brenner CA, Kieffaber PD, Clementz BA, Johannesen JK, Shekhar A, O’Donnell BF, et al. 2009. Event-related potential abnormalities in schizophrenia: A failure to “gate in” salient information? Schizophr Res 113:332–338.
   PubMed Web of Science ®Google Scholar
• Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, Tendolkar I, Bechdolf A, Pukrop R, et al. 2008. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry 64: 376–384.
   PubMed Web of Science ®Google Scholar
• Cadenhead KS, Light GA, Shafer KM, Braff DL. 2005. P50 Suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry 57:1504–1509.
   PubMed Web of Science ®Google Scholar
• Campanella S, Guerit JM. 2009. How clinical neurophysiology may contribute to the understanding of a psychiatric disease such as schizophrenia. Neurophysiol Clin 39:31–39.
   PubMed Web of Science ®Google Scholar
• Clementz BA, Geyer MA, Braff DL. 1998. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res 30:71–80.
   PubMed Web of Science ®Google Scholar
• de Wilde OM, Bour LJ, Dingemans PM, Koelman JHTM, Linszen, DH. 2007. A meta-analysis of P50 studies in patients with schizophrenia and relatives: Differences in methodology between research groups. Schizophr Res 97:137–151.
   PubMed Web of Science ®Google Scholar
• Foxe J, Yeap S, Snyder A, Kelly S, Thakore J, Molholm S. 2010. The N1 auditory evoked potential component as an endophenotype for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives, first-episode, and chronic schizophrenia patients. Eur Arch Psychiatry Clin Neurosci 261:331 339.
   Google Scholar
• Fuerst, DR, Gallinat J, Boutros NN. 2007. Range of sensory gating values and test-retest reliability in normal subjects. Psychophysiology 44:620–626.
   PubMed Web of Science ®Google Scholar
• Gratton G, Coles M, Donchin E. 1982. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 55:468–484.
   Google Scholar
• Jerger K, Biggins C, Fein G. 1992. P50 suppression is not affected by attentional manipulations. Biol Psychiatry 31:365–377.
   PubMed Web of Science ®Google Scholar
• Johannesen JK, Kieffaber PD, O’Donnell BF, Shekhar A, Evans JD, Hetrick, WP. 2005. Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophr Res 78:269–284.
   PubMed Web of Science ®Google Scholar
• Judd LL, McAdams L, Budnick B, Braff DL., 1992. Sensory gating deficits in schizophrenia: new results. Am J Psychiatry 149:488–493.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276.
   PubMed Web of Science ®Google Scholar
• Knott V, Millar A, Fisher D. 2009. Sensory gating and source analysis of the auditory P50 in low and high suppressors. Neuroimage 44:992–1000.
   PubMed Web of Science ®Google Scholar
• Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. 2000. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry 157:767–771.
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Phillips LJ. 2003. The “close-in” or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull 29:771–790.
   PubMed Web of Science ®Google Scholar
• Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Ventura J, McFarlane W. 2003. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 29:703–715.
   PubMed Web of Science ®Google Scholar
• Myles-Worsley M, Ord L, Blailes F, Ngiralmau H, Freedman R. 2004. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia. Biol Psychiatry 55:663–667.
   PubMed Web of Science ®Google Scholar
• Olincy A, Braff DL, Adler AE, Cadenhead KS, Calkins ME, Dobie DJ, et al. 2010. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Con sortium on Genetics of Schizophrenia. Schizophr Res 119: 178–82.
   Web of Science ®Google Scholar
• Patterson JV, Jin Y, Gierczak M, Hetrick WP, Potkin S, Bunney WEJ, et al. 2000. Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis. Arch Gen Psychiatry 57: 57–64.
   PubMed Web of Science ®Google Scholar
• Patterson JV, Hetrick WP, Boutros NN, Jin Y, Sandman C, Stern H, et al. 2008. P50 sensory gating ratios in schizophrenics and controls: A review and data analysis. Psychiatry Res 158:226–247.
   PubMed Web of Science ®Google Scholar
• Perneger TV., 1998. What’s wrong with Bonferroni adjustments. BMJ 316:1236–1238.
   PubMed Web of Science ®Google Scholar
• Potter D, Summerfelt A, Gold J, Buchanan RW. 2006. Review of clinical correlates of p50 sensory gating abnormalities in patients with schizophrenia. Schizophr Bull 32:692–700.
   PubMed Web of Science ®Google Scholar
• Rentzsch J, Jockers-Scherübl MC, Boutros NN, Gallinat J. 2008. Test–retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects. Int J Psychophysiol 67:81–90.
   PubMed Web of Science ®Google Scholar
• Rothman KJ. 1990. No adjustments are needed for multiple comparisons. Epidemiology 1:43–46.
   PubMedGoogle Scholar
• Schmand BA, Bakker D, Saan R, Louman J. 1991. The Dutch Reading Test for Adults: a measure of premorbid intelligence level. Tijdschr Gerontol Geriatr 22:15–19.
   PubMedGoogle Scholar
• Schulze KK, Hall MH, McDonald C, Marshall N, Walshe M, Murray RM, et al. 2007. P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biol Psychiatry 62:121–128.
   PubMed Web of Science ®Google Scholar
• Smith DA, Boutros NN, Schwarzkopf SB. 1994. Reliability of P50 auditory event-related potential indices of sensory gating. Psychophysiology 31:495–502.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Williams JB, Gibber M, First MB. 1992. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49:624–629.
   PubMed Web of Science ®Google Scholar
• van Tricht MJ, Nieman DH, Koelman JTHM, van der Meer JN, Bour LJ, de Haan L, et al. 2010. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biol Psychiatry 68:642–648.
   PubMed Web of Science ®Google Scholar
• van Tricht MJ, Nieman DH, Koelman JHTM, Bour LJ, van der Meer JN, van Amelsvoort TA, et al. 2011. Auditory ERP components before and after transition to a first psychotic episode. Biol Psychol 87:350 357.
   Google Scholar
• Wittchen HU. 1994. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review. J Psychiatr Res 28:57–84.
   PubMed Web of Science ®Google Scholar
• Yung AR. 2003. Commentary: The schizophrenia prodrome: a high-risk concept. Schizophr Bull 29:859–865.
   PubMed Web of Science ®Google Scholar
• Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips L, Nelson B, et al. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res 84:57–66.
   PubMed Web of Science ®Google Scholar
• Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, et al. 2007. Declining transition rate in Ultra High Risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 33:673–681.
   PubMed Web of Science ®Google Scholar